New App Helps Parents Identify Treatable Childhood Growth Disorders Earlier

A ground-breaking new, mobile phone app, 'GrowthMonitor' places the accurate measurement of children's height in the hands of parents and carers. Preliminary data to be presented at the Society for Endocrinology annual conference in Edinburgh suggests that the app could reliably identify treatable growth disorders, much earlier, with significant improvements in child health.

Childhood growth is a strong indicator of health and well-being in children, but delays in the diagnosis of growth disorders are common in the UK. In contrast to many European health systems, monitoring child growth has not been a priority in the UK and serious, treatable conditions are often diagnosed late. Growth failure may be the first and only sign of many chronic childhood diseases or indicate a specific growth disorder such as growth hormone deficiency (1 in 4,000 children), Noonan and Turner syndrome (each 1 in 2,500 children) and SHOX deficiency (up to 20% of undiagnosed short stature).

A reliable and accurate method for parents and carers to monitor growth at home could be a cost-effective and convenient strategy to identify those children in need of medical referral, empowering parents, raising awareness and reducing pressure on primary care services.

An interdisciplinary group, led by Professor Helen Storr, at Queen Mary University London, has developed a user-friendly app called ‘GrowthMonitor’ to do just this. Research Nurse, Dr Thilipan Thaventhiran, led the pilot testing of the ‘GrowthMonitor’ app in 79 children, showing that height data measured by the app were highly accurate when compared to gold standard clinic stadiometer measurements. The app uses a simple traffic light system, based on predetermined threshold heights, to inform parents that growth is either normal (green), to continue monitoring (amber) or to seek medical advice (red).

Dr Thaventhiran believes "The ‘GrowthMonitor’ app technology could transform our approach to childhood growth monitoring, by empowering carers to identify growth problems early, enabling much earlier diagnosis and treatment of growth disorders. It could also provide reassurance to parents whose children are growing normally thereby reducing unnecessary anxiety and referrals to paediatric services."

Following the positive pilot data obtained in a hospital setting, further testing is now underway assessing the app’s usability in the home environment. This phase is critical in evaluating the app in the hands of parents and carers, away from the hospital.

Project lead, Professor Storr says; "In line with the government drive to digitise healthcare, this type of app-based technology provides a model for healthcare innovation which is both cost-effective, convenient, accurate and reliable. Engaging patients, parents and carers in monitoring childhood growth is empowering and raises awareness of important and potentially treatable conditions."

For further information, please visit:
https://www.qmul.ac.uk/growth-monitor/

The poster "Development and testing of a novel 'GrowthMonitor' Smartphone App for growth monitoring and the detection of growth disorders" is presented at the Society for Endocrinology's annual conference, SfE BES 2021 in Edinburgh, UK.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...